These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15277339)

  • 21. [The frequency of endothelial dysfunction in patients with pseudarthrosis of long bones with hyperhomocysteinemia and associated metabolic disorder].
    Bezsmertnyĭ IuO
    Lik Sprava; 2013; (3):48-53. PubMed ID: 25016746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Homocysteine--a risk factor for atherosclerosis].
    Debreceni L
    Orv Hetil; 2001 Jul; 142(27):1439-44. PubMed ID: 11481906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Hyperhomocysteinemia and Hyperuricemia in Pathogenesis of Atherosclerosis.
    Zhao J; Chen H; Liu N; Chen J; Gu Y; Chen J; Yang K
    J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2695-2699. PubMed ID: 28986198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenesis of vascular disease in hyperhomocysteinaemia.
    Domagała TB; Undas A; Libura M; Szczeklik A
    J Cardiovasc Risk; 1998 Aug; 5(4):239-47. PubMed ID: 9919472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homocysteine and glutathione peroxidase-1.
    Lubos E; Loscalzo J; Handy DE
    Antioxid Redox Signal; 2007 Nov; 9(11):1923-40. PubMed ID: 17822368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The mechanisms of hyperhomocysteinemia in coronary heart disease].
    Gao W; Jiang N; Zhu G
    Zhonghua Yi Xue Za Zhi; 1998 Nov; 78(11):821-3. PubMed ID: 11038775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Metabolic interactions between the hyperhomocysteinemia and angiotensin-1 converting enzyme activity in Tunisian patients with coronary heart disease].
    Chalghoum A; Noichri Y; Chkioua L; Gammoudi I; Dandana A; Khelil S; Jeridi G; Baudin B; Ferchichi S; Miled A
    Ann Biol Clin (Paris); 2012 Oct; 70(5):599-604. PubMed ID: 23047907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between S-adenosylmethionine, S-adenosylhomocysteine, asymmetric dimethylarginine, and endothelial function in healthy human subjects during experimental hyper- and hypohomocysteinemia.
    Doshi S; McDowell I; Goodfellow J; Stabler S; Boger R; Allen R; Newcombe R; Lewis M; Moat S
    Metabolism; 2005 Mar; 54(3):351-60. PubMed ID: 15736113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homocysteine--a novel risk factor for vascular disease.
    Chambers JC; Seddon MD; Shah S; Kooner JS
    J R Soc Med; 2001 Jan; 94(1):10-3. PubMed ID: 11220060
    [No Abstract]   [Full Text] [Related]  

  • 30. Serum homocysteine and long-term risk of myocardial infarction and sudden death in patients with coronary heart disease.
    Haim M; Tanne D; Goldbourt U; Doolman R; Boyko V; Brunner D; Sela BA; Behar S
    Cardiology; 2007; 107(1):52-6. PubMed ID: 16763372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum total homocysteine and coronary heart disease.
    Arnesen E; Refsum H; Bønaa KH; Ueland PM; Førde OH; Nordrehaug JE
    Int J Epidemiol; 1995 Aug; 24(4):704-9. PubMed ID: 8550266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction.
    Hassan A; Hunt BJ; O'Sullivan M; Bell R; D'Souza R; Jeffery S; Bamford JM; Markus HS
    Brain; 2004 Jan; 127(Pt 1):212-9. PubMed ID: 14607791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma homocysteine levels in cardiovascular disease, malaria and protein-energy malnutrition in Sudan.
    Abdel GA; Abdullah SH; Kordofani AY
    East Mediterr Health J; 2009; 15(6):1432-9. PubMed ID: 20218135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Homocysteine as a coronary risk factor].
    Derbeneva SA; Pogozheva AV
    Vopr Pitan; 2003; 72(5):43-8. PubMed ID: 14619617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homocysteine and risk of periprocedural myocardial infarction in patients undergoing coronary stenting.
    Verdoia M; Schaffer A; Barbieri L; Cassetti E; Di Giovine G; Marino P; De Luca G;
    J Cardiovasc Med (Hagerstown); 2015 Feb; 16(2):100-5. PubMed ID: 24625566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homocysteine impaired endothelial function through compromised vascular endothelial growth factor/Akt/endothelial nitric oxide synthase signalling.
    Yan TT; Li Q; Zhang XH; Wu WK; Sun J; Li L; Zhang Q; Tan HM
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1071-7. PubMed ID: 20698860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of hyperhomocysteinemia-induced vascular endothelium dysfunction - possible dysregulation of phosphatidylinositol-3-kinase and its downstream phosphoinositide dependent kinase and protein kinase B.
    Sharma S; Singh M; Sharma PL
    Eur J Pharmacol; 2013 Dec; 721(1-3):365-72. PubMed ID: 24021535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Homocysteine and coronary events in coronary disease patients].
    Ambrosi P; Barlatier A; Artaud-Navarro A; Habib G; Ferracci A; Boussuges A; Garçon D; Bouvenot G; Luccioni R
    Ann Cardiol Angeiol (Paris); 1999 Mar; 48(3):185-9. PubMed ID: 12555379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homocysteine and coronary artery disease.
    Cheng TO
    Atherosclerosis; 1999 Aug; 145(2):419. PubMed ID: 10488972
    [No Abstract]   [Full Text] [Related]  

  • 40. Homocysteine and its role in the pathogenesis of atherosclerotic vascular disease.
    Sainani GS; Sainani R
    J Assoc Physicians India; 2002 May; 50 Suppl():16-23. PubMed ID: 12186151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.